Grade My Investments
HomeFree Stock Grades › CBLL

CeriBell, Inc. (CBLL) Stock Grade

CBLL · Healthcare

A-
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$801.4M
P/E Ratio
Revenue Growth (YoY)
+36.1%
Net Margin
-60.0%
Return on Equity
Dividend Yield
None

About CeriBell, Inc.'s fundamentals

CeriBell is a medical devices company with a market capitalization of $801.4 million that is experiencing strong revenue growth of 36.1% year-over-year. However, the company is currently unprofitable, operating at a net margin of -60.0% and reporting a net loss in its latest annual statement. The company does not pay a dividend. These metrics suggest CeriBell is in a growth phase typical of earlier-stage medical device companies, prioritizing revenue expansion while still working toward profitability.

Track CBLL free — no credit card required. Live grade + monthly AI report →